Skip to main content

Search results

90% of our funding comes from individual donors. Learn how you can support MSF’s lifesaving care with a gift.

Scroll down for content
Destroyed buildings in Gaza, Palestine on December 12, 2023.

MSF statement on UN Security Council vote for Gaza ceasefire

News Mar 25, 2024

story Mar 22, 2024

Time for $5: MSF demands Cepheid and Danaher lower the price of medical tests

Protesters hold signs protesting Danaher prices as part of the Time for $5 campaign.

story Mar 28, 2024

Eight years in Kirkuk: Hawija’s journey of recovery

Anwar Shukr Mahmoud, an MSF patient in Hawija

story Mar 27, 2024

New approach improves diagnosis and treatment of children with TB

Lab technician reviews test results in Sierra Leone.

News Mar 26, 2024

MSF calls for global emergency stockpile of Ebola treatments

MSF staff members carry a deceased Ebola patient to the morgue in Kailahun, Sierra Leone.

Speaking out about the emergencies our staff and patients witness is part of who we are. Explore our history and principles.

News & stories

9 results

Story | Sep 18, 2023

The long and winding road to affordable access to a key TB drug

Christophe Perrin, the MSF Access Campaign‘s TB advocacy pharmacist, discusses the need for secure affordable access to improved TB medicines.

Read More
An MSF doctor in India looks at an X-ray of a lung.

News | Sep 12, 2023

J&J and Cepheid must expand access to TB drug and tests

TB is curable but remains the world’s leading infectious disease killer as pharma corporations stand in the way of affordable medical tools

Read More
A patient sits at a table in front of an MSF staff member for a free X-ray at an MSF tuberculosis (TB) screening sites in Manila.

Story | Jul 13, 2023

Johnson & Johnson deal falls short for people with TB

Johnson & Johnson must end its patent monopoly on bedaquiline so generic versions of this lifesaving drug can be widely produced.

Read More
A woman in a green headscarf and her young daughter are treated for drug resistant tuberculosis at MSF’s treatment center in Kandahar, Afghanistan.

News | Apr 26, 2023

J&J must stop blocking generic versions of lifesaving TB drug

J&J’s patent monopoly continues to keep bedaquiline out of reach.

Read More
Screening session for TB

News | Mar 23, 2023

MSF applauds rejection of J&J attempt to extend TB drug patent

The rejection of the salt form of bedaquiline is welcome news for people with drug-resistant tuberculosis.

Read More
Mirror of a woman wearing a surgical face mask in Mumbai, India.

News | Nov 08, 2022

MSF: Opportunity to increase access to newer, safer TB drugs is at risk

With newer TB drugs set to go off patent in 2023, drugmakers J&J, Otsuka, and TB Alliance must remove additional barriers that block more affordable versions from entering the market.

Read More
Chetan Kharatmol, DRTB patient from Chembur

News | Oct 18, 2021

EndTB clinical trial for multidrug-resistant tuberculosis concludes enrollment

Read More
A child sits between two people in surgical masks after completing TB treatment from MSF in Papua New Guinea.

News | Sep 03, 2021

MSF: Pediatric formulations of lifesaving TB medicines must be more widely affordable and available

Read More
An MSF doctor in India looks at an X-ray of a lung.

News | Jul 28, 2021

World Hepatitis Day: MSF launches partnership to tackle hepatitis C

Read More
Hepatitis C active case finding
For Donation Inquiries 
See donor options here
 
U.S. Media Inquiries 

Reach out to the press team
 
Non-U.S. Media Inquiries 

Contact the MSF office in your country/territory.

Support our work where it’s needed most.

Your unrestricted gifts enable us to provide lifesaving medical humanitarian care on the ground and speak out about what we see.